Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Clinical trial NCT06765109 · RECRUITING

Trial details

NCT number: NCT06765109
Sponsor: Nuvalent Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Anaplastic Lymphoma Kinase-positive

Start date: 2025-07-17
Primary completion: 2029-12-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.